| Literature DB >> 31322129 |
Jac Kee Low1, Elizabeth Manias1.
Abstract
BACKGROUND: With the large amount of material that is readily available on the internet, there are endless opportunities for electronic health-literate patients to obtain and learn new information. Although novel, a Web- or mobile-based program can be a powerful way to engage adolescents and young adults (AYAs). The ongoing engagement of AYAs with chronic disease is vital not only to empower them but also to ensure a smooth transition from pediatric to adult health care.Entities:
Keywords: adolescent; disease management; self-management; systematic review; transition to adult care; young adult
Year: 2019 PMID: 31322129 PMCID: PMC6670279 DOI: 10.2196/12042
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1Study flow diagram.
Description of included studies (N=29).
| Study identity | Country | Study design | Type of chronic disease | Quality assessment |
| Abraham et al [ | United States | Exploratory qualitative design using semistructured interview | —a | SRQRb: 15.5/21 |
| Ammerlaan et al [ | Netherlands | Quantitative feasibility study using a Web-based questionnaire | Rheumatic disease | Tongc: 7/13 |
| Ammerlaan et al [ | Netherlands | Qualitative feasibility study using semistructured interview | Juvenile idiopathic arthritis | SRQR: 17/21 |
| Applebaum et al [ | United States | Mixed methodologies, cross-sectional study: questionnaire and qualitative using focus group | — | Tong: 8/14; SRQR: 9/21 |
| Ashurst et al [ | United Kingdom | 2-stage approach: stage 1 development and stage 2 evaluation using email and a Web-based questionnaire | Diabetes | Stage 2 Tong: 6/16 |
| Breakey et al [ | Canada | Pilot randomized control trial | Hemophilia | D&Bd: 19/27 |
| Coyne et al [ | Ireland | Four-phase participatory iterative approach using questionnaire, one-to-one interview, participatory workshop, and Google Analytics | Diabetes, cystic fibrosis, or congenital heart disease | Phase 1 Tong: 2/14; Phase 1 SRQR: 11/21 |
| Huang et al [ | United States | Exploratory qualitative design using a focus group | Diabetes, cystic fibrosis, or IBDe | SRQR: 15/21 |
| Huang et al [ | United States | Randomized controlled trial | Diabetes, cystic fibrosis, or IBD | D&B: 23/27 |
| Johnson et al [ | United States | Cross-sectional study: Web-based questionnaire | Juvenile arthritis | Tong: 7/14 |
| Joseph et al [ | United States | Randomized controlled trial | Asthma symptoms | D&B: 19/27 |
| Korus et al [ | Canada | Qualitative usability testing approach using semistructured interview | Solid organ transplant recipient | SRQR: 15/21 |
| Lopez et al [ | United States | Formative iterative process using semistructured interview and group interview | Congenital heart disease | SRQR: 17/21 |
| Mulvaney et al [ | United States | Randomized controlled trial | Diabetes | D&B: 15/27 |
| Mulvaney et al [ | United States | Qualitative feasibility study | Diabetes | SRQR: 11.5/21 |
| Paul [ | Australia | Two-phase, multimethod approach: phase 1 evaluation of intervention fidelity and phase 2 feasibility pre- to posttest | Diabetes | Phase 2 D&B: 14/27 |
| Peters et al [ | Australia | Multiphase, participatory user research study using participatory workshop, workbook, and user evaluation | Asthma | SRQR: 16/21 |
| Runge et al [ | Germany | Nonrandomized trial | Asthma | D&B: 17/27 |
| Scal et al [ | United States | Descriptive paper on the intervention development process | Juvenile arthritis | N/Af |
| Schneider et al [ | United States | Qualitative evaluation of user experience using semistructured interview | Asthma | SRQR: 14/21 |
| Schneider et al [ | United States | Exploratory qualitative design using semistructured interview | Asthma | SRQR: 18/21 |
| Simmons et al [ | United States | Multiphase, iterative design and development of an intervention: environmental scan, Web-based or telephone focus group, and in-person focus group | Hemophilia | SRQR: 13.5/21 |
| Slater et al [ | Australia | Exploratory qualitative design using semistructured interview and focus group | Musculoskeletal pain | SRQR: 19/21 |
| Sterling et al [ | Canada | Exploratory qualitative design using semistructured interview | Hemophilia | SRQR: 15/21 |
| Stinson et al [ | Canada | Qualitative usability testing with semistructured interview | Juvenile idiopathic arthritis | SRQR: 18.5/21 |
| Stinson et al [ | Canada | Pilot randomized controlled trial | Juvenile idiopathic arthritis | D&B: 21/27 |
| Stinson et al [ | Canada | Descriptive exploratory qualitative design using focus group and interview | Chronic pain | SRQR: 19.5/21 |
| Whittemore et al [ | United States | Multiphase mixed-methods design: qualitative using focus group and think-aloud method, followed by a feasibility and pilot study | Diabetes | Phase 1 SRQR: 8.5/21; phase 2 D&B: 13/27 |
| Zhao et al [ | Australia | Pilot study using questionnaire | Diabetes, cystic fibrosis, or IBD | Tong: 2/16 |
aNot specified or not reported.
bSRQR: Standards for Reporting Qualitative Research.
cTong: the 16-item checklist questionnaire developed by Tong et al [28].
dD&B: Downs and Black checklist for intervention efficacy trial.
eIBD: inflammatory bowel disease.
fN/A: not applicable.
Description of participant demographics.
| Study identity | Number of participantsa | Mean age (SD or range)a | Age group (n)a | Gender (male), n (%)a |
| Abraham et al [ | 20 | —b | 7-11 (4), 12-14 (9), 15-17 (7) | 8 (40) |
| Ammerlaan et al [ | IGc: 10; CGd: 9 | IG: 22.3 (17-25); CG: 20.7 (17-25) | — | IG: 1 (10); CG: (2) 22 |
| Ammerlaan et al [ | 13 | 20 (17-22) | — | 1 (8) |
| Applebaum et al [ | Questionnaire: 35; Focus group: 20 | Questionnaire: 16.9 (13-20); Focus group: — | — | Survey: 9 (26); Focus group: — |
| Ashurst et al [ | Stage 1: 6; Stage 2: 83 | Stage 1: 20.3 (3.3); Stage 2: 19.0 (2.6) | — | Stage 1: —; Stage 2: 37 (45) |
| Breakey et al [ | 29 | IG: 16.0 (1.4); CG: 16.1 (1.4) | — | 29 (100) |
| Coyne et al [ | Phase 1 questionnaire: 207, interview: 21; phase 2 co-design group: 5, telephone interview: 4, participatory workshop: 12 | — | Phase 1 questionnaire: 14-25 (207), interview participants: 14-25 (21); phase 2 co-design group: 15-25 (5), telephone interview: 15-25 (4), participatory workshop: 15-25 (12) | Phase 1 questionnaire: —, interview participants: —; phase 2 co-design group: 2 (40), telephone interview: —, participatory workshop: — |
| Huang et al [ | 10 | 20 (18-25) | — | 4 (40) |
| Huang et al [ | IG: 40; CG: 41 | IG: 17 (12-20)e; CG: 17 (12-19)e | — | IG: 17 (43); CG: 20 (49) |
| Johnson et al [ | 134 | High PedsQL_Psycho: 15.9 (—); low PedsQL_Psycho: 16.3 (—) | — | High PedsQL_Psycho: 10 (15); low PedsQL_Psycho: 12 (18) |
| Joseph et al [ | 314 | 15.3 (1.0) | — | 115 (37) |
| Korus et al [ | 21 | — | 12-14 (7), 15-17 (13), 18 (1) | 14 (67) |
| Lopez et al [ | Phase 2 expert panel: 6 | Phase 2 expert panel: 16 (15-19)e | — | Phase 2 expert panel: 2 (33) |
| Mulvaney et al [ | IG: 48; CG: 24 | IG: 15.1 (1.5); CG: 15.1 (1.3) | — | IG: 25 (52); CG: 15 (62) |
| Mulvaney et al [ | 41 | IG only: 15.1 (1.5) | — | IG only: 21 (51) |
| Paul [ | Phase 1: —; phase 2: 5 ( | — | Phase 1: —; phase 2: 14 (1), 15 (3), 17 (1) | Phase 1: —; phase 2: 3 (60) |
| Peters et al [ | 20 | 17.8 (15-24) | — | 8 (40) |
| Runge et al [ | 178 | IG1: 11.1 (2.4); IG2: 11.0 (2.2); CG: 11.5 (2.9) | — | IG1: 47 (55); IG2: 29 (66); CG: 38 (79) |
| Scal et al [ | Youth: 5; Young adults: 5 | Youth:16.2 (14-21)f; Young adults: 25.4 (22-28)f | — | Youth: 2 (40)f; young adults: 1 (20)f |
| Schneider et al [ | 16 | — | 13-18 (16) | — |
| Schneider et al [ | 20 | 14.4 (1.6) | — | 9 (45) |
| Simmons et al [ | Web-based focus group: 40; In-person message testing focus group: 19 | — | Web-based focus group: 16-17 (24), 18-19 years (16); In-person message testing focus group: 16-17 (12), 18-19 (7) | — |
| Slater et al [ | 23 | 20.8 (2.4) | — | 3 (13) |
| Sterling et al [ | 11 | 16.3 (12.8-18.3) | — | 11 (100) |
| Stinson et al [ | 19 | 15.7 (1.5) | — | 5 (26) |
| Stinson et al [ | IG: 22; CG: 24 | IG: 14.4 (1.3); CG: 14.8 (1.7) | — | IG: 7 (32); CG: 8 (33) |
| Stinson et al [ | 23 | — | 14-18 (23) | 5 (22) |
| Whittemore et al [ | Phase 1 intervention development: 3; Phase 2 randomized pilot trial: 12; program evaluation: 10 | Phase 1 intervention development: —; phase 2 randomized pilot trial: 14.4 (0.9); program evaluation: 14.0 (1.2) | — | Phase 1 intervention development: —; phase 2 randomized pilot trial: 5 (42); Program evaluation: 6 (60) |
| Zhao et al [ | 10 | 20.2 (—) | — | 3 (30) |
aCharacteristics of parent, health care professional, or healthy participants are not included.
bNot specified or not reported.
cIG: intervention group.
dCG: comparison group.
eMedian years (minimum-maximum).
fInformation was obtained from a related, secondary source.